Clinical Trial Update: Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed evaluating mobilization of autologous hematopoietic stem cells using AMD3100 (plerixafor) in combination with G-CSF for patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Mozobil (plerixafor)
• Neupogen (Filgrastim)

Snippet

Sponsor: Sanofi | Conditions: Autologous Haematopoietic Stem Cell Transplant | Phase 4 | Status: COMPLETED